AlphaSense

AlphaSense Overview

AlphaSense is an AI-powered search and market intelligence platform that empowers professionals to make informed business decisions. It harnesses the power of artificial intelligence and natural language processing to provide insights from a wide range of public and private content, including company filings, event transcripts, news, trade journals, and equity research.

Key Features

• AI-powered Search: AlphaSense utilizes its proprietary AI and NLP technology to instantly surface and track insights from millions of documents.
• Smart Synonyms: The platform offers an AI-powered search with Smart Synonyms, enabling users to discover relevant information even if it uses different terminology.
• Monitoring: AlphaSense provides custom dashboards and alerts for real-time tracking of companies, industries, and trends.
• Workflow: Users can seamlessly translate intelligence into action by collaborating securely with their entire organization.

Content

AlphaSense facilitates access to a vast content universe, drawing from over 10,000 sources. This includes:

• Data Sources: Users can search across a curated collection of high-value content from over 10,000 sources.
• Wall Street Insights: AlphaSense offers exclusive access to pertinent information from a comprehensive range of equity research.
• Expert Insights: Users can tap into the knowledge of industry operators and buy-side analysts for valuable insights.

Use Cases

AlphaSense is utilized by a diverse range of industries and professions, including:

• Corporate: It supports competitive intelligence, corporate strategy, investor relations, and corporate development.
• Financial Services: AlphaSense caters to asset management firms, hedge funds, private markets, investment & corporate banking, and sell-side research firms.
• Industries: The platform serves various sectors such as consulting, consumer/CPG, energy, financial services, industrials, healthcare & life sciences, and tech, media, telecom.

AlphaSense is trusted by 85% of the S&P 100, 75% of the top asset management firms, 80% of the top consultancies, and the 20 largest pharmaceutical companies.